The Hypothesis
I suspect that age-related stiffening of the extracellular matrix (ECM)—driven specifically by advanced glycation end-product (AGE) crosslinking—acts as a chronic biophysical agonist that pulls down the activation threshold for the MRGPRX2 receptor (Mrgprb2 in rodents). This essentially represents a "low-pass filter" failure in aging connective tissue. While young mast cells (MCs) require high-intensity mechanical stimuli to trigger Substance P (SP) release and degranulation, aged MCs likely exist in a state of chronic, low-grade degranulation. It is a fundamental shift in the mechanical-to-chemical signaling gateway.
Mechanistic Reasoning
Current models show that mechanical stress on tenocytes releases SP, which then activates MRGPRX2 on mast cells to drive calcium mobilization and ECM degradation [https://pmc.ncbi.nlm.nih.gov/articles/PMC11169467/]. However, I don't think the aging process is just a matter of higher SP volume. We are likely looking at a change in receptor sensitivity dynamics.
- Stiffness-Gated Sensitization: In aged tissues, the increased elastic modulus of the ECM provides constant mechanical feedback to residing tenocytes. This likely results in a constitutive, sub-clinical leakage of SP.
- GPCR Signal Drift: Chronic exposure to this background SP, paired with age-related changes in membrane fluidity, likely impairs GRK-mediated desensitization of MRGPRX2. This leads to "Signal Drift," where the receptor fails to internalize or reset. This effectively turns a phasic response into a chronic inflammatory leak.
- **The





























